Table 3. Subgroup analysis.
Outcomes | Group | OR and 95%CI | P value | Heterogeneity (%) | P value for heterogeneity | P value for heterogeneity between subgroups |
---|---|---|---|---|---|---|
30-day survival rate | Publication year | |||||
2005 or after | 1.48(0.78–2.78) | 0.228 | 0.0 | 0.798 | 0.674 | |
Before 2005 | 1.91(0.70–5.22) | 0.210 | 0.0 | 0.905 | ||
Study design | ||||||
Prospective | 1.86(0.87–3.96) | 0.108 | 0.0 | 0.723 | 0.562 | |
Retrospective | 1.35(0.63–2.89) | 0.436 | 0.0 | 0.947 | ||
Sample size | ||||||
100 or larger | 2.06(0.89–4.77) | 0.090 | 0.0 | 0.767 | 0.424 | |
< 100 | 1.32(0.66–2.65) | 0.433 | 0.0 | 0.947 | ||
Mean age (years) | ||||||
60 or older | 1.43(0.78–2.61) | 0.250 | 0.0 | 0.878 | 0.456 | |
< 60 | 2.34(0.74–7.46) | 0.149 | 0.0 | 0.972 | ||
Percentage male (%) | ||||||
50 or larger | 1.55(0.86–2.81) | 0.147 | 0.0 | 0.933 | 0.877 | |
<50 | 1.74(0.51–5.99) | 0.378 | 0.0 | 0.469 | ||
10-month survival rate | Publication year | |||||
2005 or after | 1.22(0.77–1.93) | 0.398 | 14.4 | 0.322 | 1.000 | |
Before 2005 | 1.06(0.25–4.54) | 0.938 | 74.3 | 0.009 | ||
Study design | ||||||
Prospective | 1.17(0.77–1.79) | 0.457 | 10.6 | 0.340 | 1.000 | |
Retrospective | 1.28(0.34–4.81) | 0.717 | 68.3 | 0.013 | ||
Sample size | ||||||
100 or larger | 1.32(0.85–2.05) | 0.217 | 0.0 | 0.859 | 1.000 | |
< 100 | 1.18(0.53–2.65) | 0.685 | 62.4 | 0.014 | ||
Mean age (years) | ||||||
60 or older | 0.96(0.45–2.05) | 0.919 | 56.2 | 0.044 | 0.256 | |
< 60 | 1.91(0.80–4.59) | 0.147 | 34.8 | 0.216 | ||
Percentage male (%) | ||||||
50 or larger | 1.13(0.58–2.22) | 0.721 | 56.6 | 0.032 | 0.577 | |
<50 | 1.69(0.52–5.52) | 0.386 | 38.5 | 0.202 | ||
20-month survival rate | Publication year | |||||
2005 or after | 1.74(0.95–3.18) | 0.074 | 0.0 | 0.562 | 0.492 | |
Before 2005 | 2.49(1.09–5.68) | 0.031 | 0.0 | 0.381 | ||
Study design | ||||||
Prospective | 1.81(0.53–6.18) | 0.344 | 48.3 | 0.145 | 0.929 | |
Retrospective | 1.94(1.07–3.50) | 0.028 | 0.0 | 0.902 | ||
Sample size | ||||||
100 or larger | 1.71(0.76–3.87) | 0.194 | - | - | 0.677 | |
< 100 | 2.13(1.16–3.92) | 0.015 | 0.0 | 0.510 | ||
Mean age (years) | ||||||
60 or older | 1.74(0.95–3.18) | 0.074 | 0.0 | 0.562 | 0.492 | |
< 60 | 2.49(1.09–5.68) | 0.031 | 0.0 | 0.381 | ||
Percentage male (%) | ||||||
50 or larger | 1.93(1.12–3.31) | 0.018 | 0.0 | 0.422 | 0.859 | |
<50 | 2.16(0.71–6.58) | 0.177 | 0.0 | 0.465 | ||
30-month survival rate | Publication year | |||||
2005 or after | 1.33(0.76–2.32) | 0.321 | 0.0 | 0.835 | 0.765 | |
Before 2005 | 1.10(0.36–3.36) | 0.872 | 0.0 | 0.861 | ||
Study design | ||||||
Prospective | 1.12(0.32–3.89) | 0.858 | 0.0 | 0.875 | 0.822 | |
Retrospective | 1.31(0.76–2.26) | 0.333 | 0.0 | 0.824 | ||
Sample size | ||||||
100 or larger | 1.23(0.65–2.35) | 0.523 | - | - | 0.870 | |
< 100 | 1.34(0.61–2.97) | 0.463 | 0.0 | 0.917 | ||
Mean age (years) | ||||||
60 or older | 1.33(0.76–2.32) | 0.321 | 0.0 | 0.835 | 0.765 | |
< 60 | 1.10(0.36–3.36) | 0.872 | 0.0 | 0.861 | ||
Percentage male (%) | ||||||
50 or larger | 1.22(0.71–2.08) | 0.474 | 0.0 | 0.971 | 0.635 | |
<50 | 1.73(0.45–6.70) | 0.426 | 0.0 | 0.473 |
*OR, odds ratio; CI, confidence interval